Literature DB >> 12116354

Grading of laboratories on CD4+ T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error.

Annalisa Kunkl1, Domenico Risso, Maria Paola Terranova, Mauro Girotto, Bruno Brando, Lorenzo Mortara, Pasquale Bruno Lantieri.   

Abstract

BACKGROUND: We addressed the definition of limits of error of %CD4+ and CD4+ counts (AbsCD4+) typical of laboratories of excellence, as well as the grading of laboratories based on the decision to take these limits as boundaries of unacceptable data.
METHODS: We studied the 99.9% confidence intervals of the means of 24 human immunodeficiency virus (HIV)+ and HIV- blood samples analyzed by 18 laboratories of the Liguria Region Quality Assessment Program (Liguria Region QALI). Regression equations of lower (L1) and upper (L2) confidence limits over the means of data cleared of unusual results were used to interpolate limits of error for mean values in the tested range.
RESULTS: L1 and L2 were symmetric around the mean and a single absolute difference (Abs Res) between the limits and the mean was found. Abs Res significantly increased over mean values (P = 0.0005 for %CD4+, P < 0.0001 for AbsCD4+). Limits were compatible with errors shown with blind replicates. Unacceptable results, outside the limits, accounted for 25% and 30% of %CD4+ and for 18% and 35% AbsCD4+ in the Liguria Region QALI and in the Piemonte Region QA Program, respectively. Limits interpolated over the median showed a similar grading. A comparable fraction of unacceptable data was also found with the method used in the U.K. National External Quality Assessment Scheme (NEQAS) immune monitoring scheme.
CONCLUSIONS: We propose the general use of these regression equations to determine bounds for unacceptable data in proficiency testing and to identify laboratories of excellence. Published 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12116354     DOI: 10.1002/cyto.10069

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  5 in total

1.  Comparison of Microcapillary Cytometry Technology and Flow Cytometry for CD4+ and CD8+ T-Cell Estimation.

Authors:  A J Kandathil; R Kannangai; S David; G Nithyanandam; S Solomon; P Balakrishnan; O C Abraham; S Subramanian; P Rupali; V P Verghese; S Pulimood; G Sridharan
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

2.  Daily quality control in CD3+ and CD4+ T cell estimation by the FACSCount system at a tertiary care center in south India.

Authors:  Veena V Ramalingam; Monika Mani; Vijayanand C Sundaresan; Ramesh J Karunaiya; Jaiprasath Sachithanandham; Rajesh Kannangai
Journal:  Clin Vaccine Immunol       Date:  2012-08-01

3.  Laboratory Accuracy Improvement in the UK NEQAS Leucocyte Immunophenotyping Immune Monitoring Program: An Eleven-Year Review via Longitudinal Mixed Effects Modeling.

Authors:  John Bainbridge; Wes Rountree; Raul Louzao; John Wong; Liam Whitby; Thomas N Denny; David Barnett
Journal:  Cytometry B Clin Cytom       Date:  2017-05-16       Impact factor: 3.058

Review 4.  CD4 immunophenotyping in HIV infection.

Authors:  David Barnett; Brooke Walker; Alan Landay; Thomas N Denny
Journal:  Nat Rev Microbiol       Date:  2008-11       Impact factor: 60.633

5.  External Quality Assessment on CD4+ T-Cell Count Using in-House Proficiency Testing Panels for CD4 Count Laboratories in Addis Ababa, Ethiopia.

Authors:  Natnael Kidanu Yibalih; Dawit Wolday; Samuel Kinde; Gebru Mulugeta Weldearegay
Journal:  Ethiop J Health Sci       Date:  2019-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.